microglia, and oligodendrocytes. A number of observations show that the vasculature is an important component of neural stem cell niches. In the developing CNS, nervous and vascular systems are both derived from the neural tube (1) . Endothelial cells and neural stem cells appear at the same stages during development and are co-localized in the neural geminal zones (2) . Invasion of spouts from the perineural vascular plexus into the ventral region of the neural tube are associated with the proliferation of neuroepithelium. In the adult brain, neural stem cells and their progeny in the subventricular zone (SVZ) of the lateral ventricle (LV) and in the subgranular zone of the dentate gyrus in the hippocampus lie close to the blood vessels (3) . It has been shown that neurogenesis and angiogenesis are coupled processes in subgranular zone (4) . In rostral migratory stream, blood vessels are tightly associated with the newborn SVZ neuroblasts and are involved in their migration (5) . Similarly, in the olfactory bulb, blood vessels serve as scaffolding for radial migration of neural progenitor cells (6) . After ischemic insult, neuroblasts of the SVZ are also found migrating along the sides of blood vessels toward the damaged sites (7) . Early studies suggested that brain endothelial cells influenced NS/P cells through the action of their secreted factors. Indeed, in vitro studies have shown that diffusible factors from endothelial cells maintain and promote NS/P cell self-renewal (8) and migration (9) .
It was recently demonstrated that neural stem cells and transit-amplifying cells in the LV-SVZ directly contact blood vessels at sites devoid of coverage by astrocyte endfeet and pericyte (5) . LV-SVZ neurogenesis and injury-induced regeneration occur at these specialized neurovasculature contact sites (5, 10 ). An important regulatory mechanism for LV-SVZ neurogenesis may lie within the cell contact interface between the blood vessels and the NS/P cells.
Communication between endothelial cells and NS/P cells appears to be a two-way street, each cell type regulates the behavior of the other. It was shown that NS/P cell-derived nitric oxide induces the endothelial expression of VEGF and BDNF (11) . BDNF and VEGF in turn activate brain endothelial cell angiogenesis. Nitric oxide also stimulates NS/P cell proliferation by activating endothelial NOS (11) . This may represent one mechanism for reciprocal regulation between neurogenesis and angiogenesis. The cellular interaction mechanisms at NS/P cell-blood vessel direct contact sites are largely unexplored. A better understanding of the molecular signals that mediate interactions between NS/P cells and brain endothelial (bEND) cells would be important not only for the maintenance and differentiation of NS/P cells but also for blood vessel regulation. In the present studies we explored the interaction mechanisms between NS/P cells and bEND cells during direct cell contact. We found that NS/P cells induce an endothelial signaling pathway and lead to the production of cytokines/chemokines. Interestingly these endothelial responses were critically dependent on the expression of a type II transmembrane serine protease in NS/P cells and involve an endothelial G s protein signal.
EXPERIMENTAL PROCEDURES
Cell Culture-NS/P cells were differentiated from the Sox1-GFP knock-in mouse ES cells (46C ES cells, obtained from Dr. Austin Smith at University of Edinburgh, UK (12) ). Differentiation of NS/P cells was carried out by placing 46C ES cells on a gelatin-coated surface in neuronal differentiation medium (referred to as N2B27 medium) as described previously (13) . GFPϩ NS/P cells were collected on day 6 using an ARIA fluorescence-activated cell sorter (BD Biosciences) and were used in the co-culture experiments. For neurosphere culture, 46C ES cell-derived NS/P cells were cultured on an uncoated surface for 6 days. The Sox1-GFP-positive NS/P cell spheroids were then collected. The day 14 mouse embryonic neurocortex neurospheres were purchased from STEMCELL Technologies (Vancouver, Canada). Adult NS/P cells were isolated from SVZ of the LV from 8 -12-week-old male FVB mouse as described previously (13) ; the mouse brain endothelial cell line bEnd.3 was purchased from the Bioscience Collection and Research Center (Hsinchu, Taiwan) and was routinely maintained in DMEM supplemented with 10% FBS.
For cell-cell contact co-culture, bEnd.3 cells were plated on 100-mm 2 cell culture dishes the previous day to allow attachment. The medium was removed, the cells were washed and changed to N2B27 medium, and NS/P cells were then laid on the top of the attached bEnd.3 cells. Over 90% of NS/P cells attached to bEnd.3 cells in 2-3 h. Twenty-four hours later, NS/P cells were detached from bEnd.3 cells by repeated pipetting, which removed almost all the NS/P cells without detaching bEnd.3 cells as monitored microscopically and by GFP fluorescent of NS/P cells. Cell purity was examined further by RT-PCR for expression of endothelial marker FLK1 and the absence of neural stem/progenitor molecule nestin. After removing detached NS/P cells, bEnd.3 cells were detached from the culture dish with trypsin. All of the cells were then collected by centrifugation. For Fig. 2B , NS/P cells and bEnd.3 cells were mixed and seeded on a coverslip in endothelial cultural medium containing low serum (1%). After the cells attached (within 3 h), the medium was replaced with N2B27 medium and co-cultured for 24 h. For noncontact co-culture, bEnd.3 cells were allowed to attach overnight to the 6-well plate; Falcon Transwells with pore sizes of 8 m (BD Labware, Franklin Lakes, NJ) were placed on each well, and Sox1-GFPϩ NS/P cells were then added into the Transwell. Twenty-four hours later, the Transwell was removed, and bEnd.3 cells were collected as described above. Reagents for cell culture were all from Invitrogen. In cultures where toxin or inhibitor was tested, they were added directly to the medium. Pertussis toxin (PTX), cholera toxin (CTX), and SB203580 were from Sigma. The recombinant mouse MTP protein (purchased from R & D System) is the catalytic serine protease domain and has specific activity Ͼ4,000 pmol/min/g supplied by the manufacturer. The recombinant MTP protein was either added directly to the medium or coated on the surface of culture dishes prior seeding bEnd.3 cells.
RNA Isolation and RT-PCR-Total RNA was prepared using RNeasy mini kit (Qiagen) following the manufacturer's protocol. RNA integrity was assessed by electrophoresis, and RNA concentration was measured with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, Waltham, MA). First strand cDNA was synthesized from 1 g of RNA using Superscript III reverse transcriptase and oligo(dT) primers (Invitrogen). The resulting cDNA was then used in PCRs. Gene-specific primers were as follows: S15 (mouse ribosomal protein S15): forward, 5Ј-TTCCGCAAGTTCACCTACC-3Ј, and reverse, 5Ј-TGCT-TCACGGGTTTGTAGGT-3Ј; MTP: forward, 5Ј-CACTTCC-ATTATCGGAATGTGCG-3Ј, and reverse, 5Ј-GGATGTCG-CCGGTCAGTATTGGTTATCA-3Ј; IL6: forward, 5Ј-GTT-GTGCAATGGCAATTCTG-3Ј, and reverse, 5Ј-TGGTCTTG-GTCCTTAGCCAC-3Ј; FLK1 (vascular endothelial growth factor receptor 2): forward, 5Ј-CC AAAAACCAATATGCCCT-GAT-3Ј, and reverse, 5Ј-TCTC TCAGTACAATGCCTG-AATCTTC-3Ј. IL24: forward, 5Ј-GATGACATCACAAGCA-TCCG-3Ј, and reverse, 5Ј-ATTTCTGCATCCAGGTCAGG-3Ј; CXC motif chemokine 10 (CXCL10): forward, 5Ј-ATGAA-CCCAAGTGCTGCC-3Ј, and reverse, 5Ј-TTCATCGTGGC-AATGATCTC-3Ј; and nestin: forward, 5Ј-GGGAGCTCGGA-GCCCAAGGA-3Ј, and reverse, 5Ј-GGGCATGGCTGC-CCTCATGG-3Ј. siRNA and Plasmid Transfection-Transfection of siRNA or mammalian expression plasmid was performed using Lipofectamine 2000 (Invitrogen) as described previously (13) . MTP knockdown or overexpression was checked by RT-PCR or Western blot. The siRNA against mouse St14 and a control siRNA with no target (nonsilencing siRNA) were purchased from Qiagen. The MTP overexpression plasmid is a pSPORT6-CMV vector carrying the full-length mouse MTP cDNA.
Western Blot-Cell lysates were prepared in buffer containing 50 mM Tris-HCl (pH7.5), 1 mM EDTA, 1% Triton X-100, protease inhibitors, and phosphatase inhibitors. After 10 min of centrifugation at 13,000 ϫ g, the supernatants were collected, and protein concentrations were determined by SuperSignal West Pico protein assay kit (Pierce) using bovine serum albumin as a standard. An equal amount of protein was subjected to SDS-PAGE, followed by Western blot as described (14) . Antibodies to p38 MAP kinase, phospho-p38 MAP kinase, PKC␣, and phospho-PKC␣ were all from Cell Signaling Technology (Danvers, MA).
Immunofluorescence Staining of Cell Culture-Cell staining followed the procedure described previously (13) . In brief, the cells were seeded on coverslips. After culture, they were fixed, permeabilized with 0.5% Triton X-100, and blocked with 4% horse serum. After incubation with primary antibody, the cells were then incubated with green or red fluorescence-conjugated secondary antibodies. The cell nuclei were counterstained with DAPI and analyzed using epifluorescence microscope (Olympus BX51).
ELISA-Cytokines released into the culture medium was assayed by ELISA according to the manufacturer's instructions. ELISA for mouse IL6, mouse IL24, and mouse CXCL10 were from Invitrogen, UCSN Life Science Inc. (Wuhan, PRC), and R & D Systems, respectively. Purified recombinant protein of each cytokine was used to obtain a standard curve for each assay to determine the concentration of each cytokine in the cell conditioned medium.
GTPase Activity Assay-GTPase activity of cell lysates was measured using a colorimetric assay kit (Innova Biosciences, Cambridge, UK) following the manufacturer's protocol. In brief, cell lysate or buffer was mixed with GTP substrate: the PiColorLock Gold reagent mix. The stabilizer was then added and incubated for 30 min. The absorbance was measured at 650-nm wavelength. A phosphate standard included in the package was used to calculate the specific GTPase activity in each sample of cell lysate.
Statistical Analysis-The data are presented as means Ϯ S.D. derived from three to five independent experiments. Twogroup t test was used for comparison between groups. For multiple-group comparisons, data were tested by one-way analysis of variance, and Bonferroni adjustment was used for within group comparisons.
NS/P Cell Differentiation with IL6 or Co-culture Conditioned Medium-NS/P cells were seeded on PDL/laminin-coated culture dishes and cultured in N2B27 medium in the absence or presence of recombinant IL6 protein or the conditioned medium before or after IL6 depletion. The medium was changed every other day and cells were harvested after 7 days of culture. The conditioned medium of NS/P cell-bEND cell contact co-culture were harvested after 24-hours and concentrated by Ultra-4 molecular cutoff at 5 kDa (Millipore-Amicon). For IL6 depletion, the concentrated conditioned medium was incubated with IL6 antibody, and the antibody-bond fraction was then removed by protein-A agarose beads. Depletion of IL6 was confirmed by ELISA.
RESULTS

NS/P Cell-induced Chemokine/Cytokine Production in bEND
Cells by Direct Contact-NS/P cells cultured directly on bEND cells attached to bEND cells after short incubation. Fig. 1A shows that expression of IL6, IL24, and CXCL10 in bEND cells was induced by the attached NS/P cells. Expression of endothelial molecule VEGF receptor 2 (FLK1) in bEND cells collected after contact co-culture with NS/P cells was similar to that in bEND cells without co-culture. The NS/P marker nestin was not detected in bEND cells after contact co-culture with NS/P cells. The expression of FLK1 and nestin indicated that the endothelial cells collected after contact co-culture were sub- stantially free of NS/P cells. IL6, IL24, or CXCL10 were undetectable in NS/P cells (Fig. 1A , NPC) whether they were cultured without ( (Fig. 1A , Co-Cult) with NS/P cells, IL6, IL24, and CXCL10 in bEND cells were significantly increased. In contrast to contact co-culture (Fig. 1, A and B, Cont, Co-Cult), IL6, IL24, and CXCL10 in bEND cells co-cultured with NS/P cells in a Transwell (Fig. 1B , N-Cont, Co-Cult), a noncontact co-culture condition, were not induced. Brain endothelial cells cultured with the conditioned medium of NS/P cell culture did not exhibit increased expression of these genes either.
3 Fig. 1C shows that the secretion of IL6, IL24, and CXCL10 proteins after contact co-culture with NS/P cells (Fig. 1C , Cont, Co-Cult), but not in Transwell co-culture (Fig. 1C , No-Cont, Co-Cult), was three to four times greater than bEND cells without co-culture. Evidently, endothelial IL6, IL24, and CXCL10 induction occurs only in cells in direct contact with NS/P cells. The NS/P cells used in these cultures were differentiated from mouse embryonic stem cells. Identical results were observed in bEND cells in contact co-culture with NS/P cells isolated either from SVZ of the adult mouse brain LV (Fig. 1D , SVZ) or from neural cortex of 14-day mouse embryo (Fig. 1D, E14 ), clearly demonstrating that induction of endothelial cytokine/chemokine is a general feature of NS/P cells. These data demonstrate that endothelial expression of cytokines/chemokines is induced by cell contact between NS/P and bEND cells.
Endothelial p38 MAPK Is Activated by Contact with NS/P Cells in Culture-Our data suggest that signaling between NS/P and bEND cells takes place during cell-cell contact interaction and results in induction of endothelial cytokine/chemokine expression. We investigated whether p38 MAPK or PKC␣ was activated in bEND cells by contact with NS/P cells. We found that p38 MAPK protein ( Fig. 2A, p38 ) was expressed in both NS/P ( Fig. 2A, NPC) and bEND cells ( Fig. 2A, bEND) . In NS/P cells, p38 MAPK was present in the active, phosphorylated state ( Fig. 2A , * p38), and it was not altered by co-culture with bEND cells (Fig. 2A , * p38 in NPC under Co-Cult). p38 MAPK proteins in bEND cells, on the other hand, were not phosphorylated until after contact co-culture with NS/P cells ( Fig. 2A, bEND , Co-Cult). PKC␣ was not detected in NS/P cells; nor was its expression induced by co-culture with bEND cells (Fig. 2A,  PKC in NPC) . PKC␣ was present in bEND cells, but it was in a phosphorylated state; neither its expression nor its phosphorylation was affected by co-culture with NS/P cells ( lial p38 MAPK, not PKC␣, is activated by NS/P cells during cell contact.
Cell contact induction of endothelial p38 MAPK phosphorylation was checked by immunofluorescence cell staining. Fig.  2B shows that bEND cells in contact with GFP-positive NS/P cells (Fig. 2B , green fluorescence) were highly stained by antibody to the phosphorylated p38 MAPK (Fig. 2B, red fluorescence, arrowheads) . Cells that are not in contact with NS/P cells, on the other hand, were either negative or weakly stained (Fig.  2B, arrows) . Weak staining of anti-phosphorylated p38 MAPK was observed occasionally in bEND cells without co-culture (Fig. 2B, left panel in the box) or in bEND cells co-cultured with NS/P cell in Transwell (Fig. 2B, right panel in the box) , suggesting basal staining of phosphorylate p38MAP in uninduced bEND cells. Same as that shown in Fig. 2A , p38 MAPK are phosphorylated in NS/P cells whether or not they were in contact with bEND cells (Fig. 2B co-stain of GFP and p38 * ). Cell staining further confirmed that p38 MAPK activation in bEND cells is promoted by contact with NS/P cells.
To investigate whether p38 MAPK signaling is responsible for NS/P cell-induced endothelial IL6, IL24 or CXCL10 expression, co-cultured bEND-NS/P cells were treated with p38 MAPK inhibitor SB203580. In the presence of SB203580, NS/P cells failed to induce endothelial IL6 and CXCL10 expression, showing that induction of these endothelial molecules is mediated by p38 MAPK activation induced during co-culture. IL24 expression induced by NS/P cells, however, was not affected much by SB203580 (Fig. 2C, ϩp38I , Co-Cult), suggesting that p38 MAPK signaling is not the main responsive pathway for IL24 induction. These data demonstrate that NS/P cells in contact with bEND cells activate endothelial p38 MAPK, which can lead to overproduction of some (if not all) endothelial cytokines/chemokines.
Endogenous Expression of MTP in NS/P Cells Is Critical for Endothelial p38 MAPK Activation and Endothelial
Chemokine/Cytokine Induction during Co-culture-The observations described above suggested that cell to cell signaling systems exist at the cell contact interface between NS/P cells and bEND cells. We recently showed that the type II transmembrane serine protease matriptase (MTP) is expressed in NS/P cells (13) . Considering its cell surface locality and its substrate diversity, MTP represents a candidate NS/P cell membrane activator protein for inducing endothelial p38 MAPK signaling and the subsequent cytokine/chemokine expression. We tested this possibility by investigating the effect of knocking down the MTP expression in NS/P cells. MTP is highly expressed in NS/P cells; only a small amount of expression was detected in bEND cells (Fig. 3A , No Co-Cult) (13) . Consistent with the results in Fig. 1 , contact co-culture with NS/P cells induced endothelial IL6 mRNA expression (Fig. 3A , CT Co-Cult). Contact of NS/P cells and bEND cells did not change the expression of MTP in either cell type (Fig. 3A , CT Co-Cult). MTP mRNA expression in NS/P cells was reduced by specific siRNA (Fig. 3A, M-KD  NPC) , and it remained knocked down during the course of coculture with bEND cells (Fig. 3A, KD Co-Cult) . These MTP knockdown cells were unable to induce endothelial IL6 mRNA during contact co-culture (Fig. 3A, KD Co-Cult) . The ability of NS/P cells to induce endothelial CXCL10 in contact was also impaired by MTP knockdown (Fig. 3B) . Interestingly, although IL24 induction was not affected by p38 MAPK inhibitor (Fig. 2) , it was impaired by MTP knockdown (Fig. 3B) , suggesting that MTP can activate additional endothelial signaling pathways. Semiquantitative RT-PCR is shown in Fig. 3C . Exponential amplification for IL6, IL24, and CXCL10 in bEND cells without co-culture (Fig. 3C , No Co-Cult) or co-cultured with MTP knockdown NS/P cells (Fig. 3C , M-KD Co-Cult) occurred between PCR cycles 25-27. After co-culture with NS/P cells, however, expression of these three molecules reached plateau before or around PCR cycle number 26 (Fig. 3C, Ctrl Co-Cult) , confirming that induction of these transcripts in bEND cells by the NS/P cells they directly contact to is dependent on MTP. At the protein level, secretion of all three proteins was induced three or four times after contact with NS/P cells (Fig. 3D,  ϩCTRL NPC) . Cells in contact with MTP knockdown NS/P cells (Fig. 3D, ϩM-KD NPC) , on the other hand, expressed all three proteins approximately the same levels as that in cells without co-culture (Fig. 3D, No NPC) . Consistent with their mRNA expression, induction of endothelial IL6, IL24, and CXCL10 proteins was lost in MTP knockdown NS/P cell. MTP knockdown NS/P cells also lost their ability to induce endothelial p38 MAPK activation in co-culture (Fig. 3E, ϩM-KD NPC) .
Transfection of the MTP expression plasmid into MTP knockdown NS/P cells (Fig. 3F , M-KD/pM) restored MTP expression (Fig. 3F, gel image) . These cells regained their ability to induce endothelial IL6, IL24, and CXCL10 in contact co-culture (Fig. 3F, graph, M-KD/pM) . These data confirmed that NS/P cells induction of endothelial IL6, IL24, and CXCL10 is a specific effect of MTP. Transfection of MTP expression vector into control NS/P cells induced approximately the same amount of IL6, IL24, or CXCL10 (Fig. 3F, graph, pM) . It is obvious that NS/P cell induction of endothelial IL6 and IL24 have reached the maximal level because overexpression of MTP, whether in the control or in MTP knockdown NS/P cells, did not induce these molecules much higher than the control NS/P cells (Fig. 3, D, and F, dark dotted lines) .
The influence of MTP in these endothelial cell effects was further examined by overexpressing MTP in bEND cells. As shown in Fig. 4 , MTP expression is elevated in bEND cells carrying the MTP-expressing plasmid (pMTP) (mRNA in Fig. 4A ; protein in Fig. 4C ). Ecotopic expression of MTP (Fig. 4A , pMTP) in bEND cells increased the p38 MAPK phosphorylation (Fig. 4A , * p38) that is accompanied by elevated IL6, IL24, and CXCL10 mRNA (Fig. 4B) . The secreted IL6 protein was increased over 9-fold in MTP-overexpressing bEND cells (Fig.  4C) . These data clearly demonstrate that MTP is a crucial signaling activator for brain endothelial p38 MAPK activation and cytokine/chemokine production.
Brain Endothelial Guanine Nucleotide-binding Protein (G Protein) Is Signaling Target of Neural MTP-To determine the endothelial surface component that receives signaling from NS/P cell surface MTP, we looked into cell surface signaling molecules that could be activated by MTP. Protease-activated receptors (PARs) are members of the G protein-coupled receptor (GPCR) family. There are currently four members in the family: PAR1, PAR2, PAR3, and PAR4 (15). PAR2 has been reported to be activated by MTP, whereas PAR1, PAR3, and PAR4 are poor substrates of MTP (16) . It is conceivable that PAR2 may serve as the brain endothelial surface target for NS/P MTP. However, we did not detect PAR2 in bEND cells (Fig. 5A,  PAR2) . To verify the involvement of the PAR family in the present cell system, we checked the effect of another PAR protein: PAR1, which we detected in bEND cells (Fig. 5B) . PAR1-specific siRNA significantly reduced PAR1 expression in bEND cells (Fig. 5B, siPAR1) , but it did not affect IL6, IL24, or CXCL10 induction by NS/P cells in co-culture (Fig. 5B) . The PAR family apparently was not involved in NS/P-bEND cell signaling.
During NS/P cell-bEND cell contact co-culture, brain endothelial GTPase activity was activated (Fig. 6, ϩCTRL NPC) .
Knocking down of MTP in NS/P cells significantly impaired their ability to promote endothelial GTPase activation (Fig. 6 , ϩM-KD NPC). To investigate whether MTP-mediated activation of brain endothelial GTPase resulted from G protein activation, the effect of PTX and CTX was examined. PTX is an inhibitor of G i and G o proteins, and CTX is an inhibitor of G s protein. PTX or CTX did not affect the overall growth of NS/P cells or bEND cells. 3 PTX and CTX both achieved ϳ75% inhibition of the NS/P cell-induced endothelial GTPase activity at 0.1 ng/ml of concentration (Fig. 7A) . Increasing the concentration of CTX but not of PTX further reduced GTPase activation and completely inhibited NS/P cells induced endothelial GTPase activation at 2 g/ml (Fig. 7A) . NS/P cell-induced endothelial IL6 production was impaired ϳ25% by PTX at all tested concentrations (Fig. 7B, PTX) . Using the same range of concentrations, CTX inhibited endothelial IL6 induction profoundly and returned it to ground level (Fig. 7B, CTX in  bENDϩNPC) . Similarly, NS/P cell-induced endothelial IL24 and CXCL10 were both returned to ground level by CTX (Fig,  7C, CTX in bENDϩNPC) . p38 MAPK activation in bEND cells could not be induced by NS/P cells in the presence of CTX (Fig.  7D) . Protein kinase A inhibitor K5739 did not influence the p38 MAPK activation induced by NS/P cells (Fig. 7D) , ruling out the involvement of adenyl cyclase in this cell system. Altogether, these data showed that during NS/P and bEND cell-cell communication, MTP in NS/P cells induces activation of the CTXsensitive G s protein in bEND cells, probably through activation of GPCR. The known MTP activating receptor PAR2, however, was not the responsive endothelial GPCR in CNS neurovascular niches. 
Recombinant MTP Protease Domain Has Little Effect on Brain Endothelial
Responses-There are released active forms of full-size MTP in NS/P cell culture. 4 However, NS/P cells co-cultured with bEND cells in a Transwell (Fig. 1) or the conditioned medium of NS/P cells 3 failed to induce endothelial cytokine/chemokine expression. It might be that there is not sufficient amount of active MTP released from NS/P cells to achieve their effects on bEND cells. To evaluate whether this is the case, we used exogenous recombinant protein in bEND cell culture. The addition of MTP recombinant protein to bEND cell culture did not induce IL6, IL24, or CXCL10 mRNA (Fig.  8A, ϩrMTP) or protein (Fig. 8B, ϩrM) . Endothelial GTPase was not activated by the added recombinant protein either (Fig.  8C, ϩrM) . To make sure that the added recombinant MTP protein is in contact with bEND cells, we also coated the protein on the culture dishes. IL6, IL24, or CXCL10 in bEND cells cultured on recombinant MTP-coated surface, however, were not induced (Fig. 8B, Att to rM) . GTPase activation in these cultures were not induced much either (Fig. 8C, Att to rM) . The recombinant protein used in these studies is the active protease domain of MTP. These results demonstrated that MTP protease activity by itself is not sufficient to induce brain endothelial responses, even if it is in close vicinity to bEND cells. Evidently, NS/P cell-associated full-length MTP protein is essential to induce brain endothelial responses.
Endothelial IL6 in Contact Co-culture Promotes NS/P Cell Differentiation-Because IL6 promotes both gliogenesis and neurogenesis of NS/P cells, we decided to investigate the significance of NS/P cell-induced endothelial IL6. We examined whether the endothelial IL6 induced by NS/P cells affects NS/P cell differentiation. Under differentiation culture conditions, recombinant IL6 protein promoted NS/P cell differentiation to astrocyte and neuron as measured by expression of glial protein GFAP and neuron protein ␤-tubulin III (TuJ1) (Fig. 9, rIL6) confirming the presence of IL6 responsive components in the culture. NS/P cells cultured with conditioned medium collected from NS/P cell-bEND cell co-culture (Fig. 9, CM) produced higher levels of GFAP and ␤-tubulin III proteins than NS/P cells cultured in their regular differentiation medium (Fig. 9, CTRL) , indicating enhanced glial and neuronal differentiation by the co-culture conditioned medium. Removal of IL6 protein from the co-culture conditioned medium (Fig. 9 , DP-CM) reduced the ability to promote astrocyte and neuron differentiation as shown with reduced expression of GFAP and ␤-tubulin III.
DISCUSSION
NS/P cells and microvasculature are thought to be regulated reciprocally. Most studies on NS/P cell vasculature have focused on how endothelial cells and their diffusible endothelial factors regulate NS/P cell properties. Our studies provided evidence that direct cell contact signaling exists between NS/P cells and bEND cells. This direct cell interaction allowed NS/P cells to activate brain endothelial signaling and gene expression. We demonstrated that the brain endothelial cytokines/ chemokines induced by NS/P cells during direct cell contact are critically dependent on the NS/P cell-derived type II transmembrane serine protease MTP. MTP on the surface of NS/P cells caused activation of brain endothelial G s protein, which in turn led to activation of endothelial p38 MAPK and resulted in enhanced expression of some cytokines/chemokines.
Recombinant protein of MTP protease domain added to brain endothelial culture or immobilized to the culture dishes in contact with bEND cells could not induce brain endothelial signaling activation or cytokine/chemokine expression. Fulllength active forms of MTP released in NS/P cell culture failed to induce brain endothelial responses either. Only when NS/P cells and bEND cells are in direct contact and only when MTP is present in NS/P cells can brain endothelial cell signaling activation and cytokine/chemokine expression be stimulated. This differs from human umbilical vein endothelial cells that soluble protein of MTP protease domain is sufficient to induce their cellular response (20) . Although our observations did not rule out the importance of MTP protease activity in brain endothelium, these data demonstrated that MTP at the cell contact sites is crucial for NS/P-bEND signaling interaction. The observation that bEND cells cultured on top of the immobilized recombinant MTP had little response implied that other parts of MTP protein may be important on NS/P-bEND communication as well. It is possible that additional factors at the cell contact sites are required for MTP to achieve its action. Our studies did not exclude effects from other factors in NS/P-bEND cell interaction. The extracellular part of MTP contains multiple CUB (Cls/Clr urichin embryonic growth factor, bone morphogenic protein-1) domains and low density lipoprotein receptor class A domains that are thought to be involved in protein-protein interaction. It is conceivable that these domains bring additional factors to the cell contact sites for proper action of MTP.
Recently, it is shown that in the neurogenic niches of LV in brain, the slowly dividing neural stem cells, and their rapidly dividing progeny are frequently in direct contact with blood vessels (5, 10) . These direct cell contact sites are also the cell proliferation "hot spot" (5, 10) . Contact of NS/P cells with blood vessels would allow direct access of vascular-derived signals. It would allow NS/P cells to directly affect the behavior of endothelial cells as well. The primitive neural stem cell subpopulation B1 actually contacts both the ventriclar surface and the blood vessel, which allow access and transfer information between the compartments (17) . Brain endothelial cytokine/ chemokine induced by NS/P cells could provide feedback regulation to NS/P cell properties such as differentiation or migration. Endothelial factors induced by the NS/P cells could also affect other cell types in the LV neurogenic niches such as astrocytes and microglia to influence NS/P cell functions. Our studies provided evidence that NS/P cell-derived MTP is a control molecule in the cell-cell direct communication of neurovascular niche. Activation of the endothelial G s protein is one mechanism through which NS/P cells regulate brain endothelial responses. NS/P cell-derived MTP and endothelial G s protein activation could assure tight and highly localized regulation at cell-cell contact sites, which is clearly vital for the specialized neurovascular niches in brain neurogenic LV.
The heterotrimeric G proteins consist of ␣, ␤, and ␥ subunits. They function to transduce signals from receptors to intracellular effectors. In the absence of stimulation, ␣ subunit of the G protein is GDP-bound and is associated with ␤ and ␥ subunits. Agonist binding of the receptor promotes association of the intracellular domain to the heterotrimeric G protein and induces exchange of GTP for GDP binding to G␣ subunit. The GTP-bound G␣ subunit dissociates from the G␤␥ complex, and each of these subunits activates downstream responsive effectors. The intrinsic GTPase activity of the G␣ subunit hydrolyzes the bound GTP to GDP, allowing reassociation of G␣ to G␤␥, and returns the heterotrimer to its inactive state until activation by agonist binding (18) . Although our GTPase assays did not exclude activity coming from non-G protein molecules, the effect of CTX argues that endothelial G s protein is the main source of GTPase activity resulting from activation of an endothelial GPCR by the NS/P MTP.
GPCR is the largest family of transmembrane signaling molecules that induce G protein activation. The PAR family of GPCR is activated by an unusual irreversible proteolytic mechanism. Cleavage of the amino-terminal exodomain of PARs generates a new amino terminus functioning as a ligand that binds and activates the receptors (19) . Presently, PAR2 is the (0) or presence of 1 ng/ml CTX (ϩCTX) or KT5720 (ϩKT5720). Actin is the internal loading control for Western blot assay. The graph shows quantitation of chemiluminescence by densitometry. The value of phosphorylated p38 was normalized to that of the total p38 for each sample; the resulting value was then normalized to that of bEND cells without co-culture that is set at 1. Toxin-treated cultures were compared with zero-toxin-treated cultures. **, p Ϲ 0.01; ***, p Ϲ 0.001.
only GPCR identified to be activated by MTP. MTP activation of PAR2 was recently shown to induce IL6 expression in human umbilical vein endothelial cells (20) . In bEND cells, however, PAR2 was not present. PAR members are capable of activating G q/11 , G i/o/z , and G 12/13 signaling responses (15) . In bEND cells, however, G s protein was the major brain endothelial G protein activated by NS/P MTP. Together these data suggest that the PAR family of GPCR is not involved in NS/P-bEND cell communication and that other brain endothelial GPCRs exist to serve as the target molecule of NS/P cell-derived MTP. Our data, however, could not determine definitively whether this is a direct proteolytic activation by MTP or an indirect activation mediated by MTP.
IL6 is a multifunctional neurotrophin and cytokine. Besides its function in immune and inflammatory responses, IL6 plays an important role in CNS vascular development and vascularization, under both normal conditions and during the healing of brain injuries (21) . IL6 may function as a neuron-protective agent within the brain to protect neurons from oxidative damage. It promotes neurite outgrowth and neuronal survival (22) , and it supports axonal regrowth and network repair in CNS following lesions (23) . Importantly, it promotes gliogenesis and neurogenesis of NS/P cells (24, 25) . Chemotactic activity has been attributed to CXCL10 for T cells, NK cells, and dendritic cells. Its expression is linked with many T cell-mediated inflammatory diseases (26) . In the CNS, CXCL10 was shown to associate with viral infection-promoted neuronal apoptosis. Therapeutic neutralization of CXCL10 in a model of spinal cord injury reduces neuroinflammation, apoptosis, and neuronal loss (27) . On stem or progenitor cells, CXCL10 has been shown recently to be essential for the mobilization of rat neural pro- . NS/P cell-induced endothelial IL6 promotes glial and neural differentiation of NS/P cells. Expression of glial protein GFAP and early neuron protein TuJ1 in NS/P cells cultured under differentiation conditions in the absence (CTRL) or presence of recombinant IL6 protein (rIL6) or cultured with conditioned medium collected of NS/P-bEND cells in contact co-culture before (CM) or after (DP-CM) removal of IL6 protein by specific antibody. Actin is the internal loading control for Western blot assay.
genitor cells (28) , human hematopoietic stem cells (29) , and mesenchymal stem cells (30) . In the NS/P cell vascular niches, endothelial CXCL10 might act on NS/P cells as a mobilization factor. IL24 is the protein product of melanoma differentiationassociated gene 7. IL24 is classified as a cytokine of the IL10 family because of its chromosomal localization, sequence homology, and functional properties. Originally identified as a tumor suppressor molecule, IL24 has anti-cancer properties for a broad range of tumors (31) (32) (33) (34) (35) . Little is known about its function in brain or in NS/P cells. In skin, IL24 is involved in the "resolution phase" of wound healing when the keratinocytes revert to their normal, nonproliferating, differentiated state (36) . It is possible that IL24 participates in a similar healing process during brain injury.
In summary, our studies revealed a novel cell communication in neural stem cell vascular niche that involves direct interaction between the NS/P membrane protease and the bEND G s protein. Our findings advanced our understanding of cell contact communication in neurovascular niches. Our studies further unveiled the functional and regulatory complexity of MTP.
